期刊
GENE THERAPY
卷 18, 期 11, 页码 1052-1062出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/gt.2011.54
关键词
oncolytic adenovirus; somatostatin; neuroendocrine tumors; carcinoid; neuroblastoma; proximity ligation
类别
资金
- Swedish Cancer Society [08-0582, 10-0105]
- Swedish Research Council [K2008-68X-15270-04-3]
- Gunnar Nilsson's Cancer Foundation [E50/08]
- Swedish Children Cancer Foundation [PROJ08/006]
We have previously described the oncolytic adenovirus, Ad(CgA-E1A-miR122), herein denoted Ad5(CgA-E1A-miR122) that selectively replicates in and kills neuroendocrine cells, including freshly isolated midgut carcinoid cells from liver metastases. Ad5(CgA-E1A-miR122) is based on human adenovirus serotype 5 (Ad5) and infects target cells by binding to the coxsackie-adenovirus receptor (CAR) and integrins on the cell surface. Some neuroendocrine tumor (NET) and neuroblastoma cells express low levels of CAR and are therefore poorly transduced by Ad5. However, they often express high levels of somatostatin receptors (SSTRs). Therefore, we introduced cyclic peptides, which contain four amino acids (FWKT) and mimic the binding site for SSTRs in the virus fiber knob. We show that FWKT-modified Ad5 binds to SSTR2 on NET cells and transduces midgut carcinoid cells from liver metastases about 3-4 times better than non-modified Ad5. Moreover, FWKT-modified Ad5 overcomes neutralization in an ex vivo human blood loop model to greater extent than Ad5, indicating that fiber knob modification may prolong the systemic circulation time. We conclude that modification of adenovirus with the FWKT motif may be beneficial for NET therapy. Gene Therapy (2011) 18, 1052-1062; doi:10.1038/gt.2011.54; published online 14 April 2011
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据